This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University System of Maryland. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Guanjun Xia: Innovator in Immune Response Modulation
Introduction
Guanjun Xia is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of immunology through his innovative research and patenting efforts. His work focuses on developing materials and methods that can modulate immune responses, which is crucial for treating various diseases.
Latest Patents
Guanjun Xia holds a patent for "Small molecule inhibitors of Lck SH2 domain binding." This invention provides materials and methods for modulating an immune response. The applications of this patent are particularly relevant for treating diseases associated with aberrant immune responses, including autoimmune diseases such as rheumatoid arthritis. He has 1 patent to his name.
Career Highlights
Guanjun Xia is affiliated with the University System of Maryland, where he conducts his research. His work has garnered attention for its potential impact on therapeutic strategies for immune-related conditions. His innovative approach to immune modulation showcases his commitment to advancing medical science.
Collaborations
Guanjun Xia has collaborated with esteemed colleagues, including Jun Hayashi and Alexander MacKerell. These partnerships enhance the research environment and contribute to the development of groundbreaking solutions in immunology.
Conclusion
Guanjun Xia's contributions to the field of immunology through his patent and research efforts highlight his role as an innovator. His work has the potential to significantly impact the treatment of autoimmune diseases and improve patient outcomes.